Jicama

1. What conditions has Jicama been studied for?

• Type 2 diabetes / hyperglycemia / insulin resistance: Studied in multiple animal and model-organism systems, including db/db mice, STZ-induced diabetic mice, high-sucrose diet (HSD) mice, and a high-fat diet Drosophila model.

• Postprandial (after-meal) blood glucose spikes: Evaluated in STZ-induced diabetic mice and normal mice via inhibition of carbohydrate-digesting enzymes and post-meal glucose response.

• Obesity-related outcomes: Body weight gain and white adipose tissue (WAT) mass were assessed in HSD-fed mice given jicama fiber.

• Oxidative stress (in a diabetes model context): Reactive oxygen species (ROS) were measured in high-fat diet Drosophila treated with probiotics plus jicama-derived prebiotic (inulin).

• Low glycemic index / glycemic impact of the food itself: Jicama roots were characterized across maturation stages and classified as low glycemic index (GI < 25) in the polysaccharide-focused study.

• Antioxidant capacity (food composition): In an Andean Ecuadorian foods survey, jícama (Smallanthus sonchifolius) was reported as the tuber with the highest total phenolics, flavonoids, and total antioxidant capacity among tubers studied.

• Non-health/industrial applications: Jicama peroxidase for dye removal; jicama starch biocomposites; jicama starch in fermented milk/probiotic delivery; synbiotic powder formulations with jicama powder; microencapsulation using jicama starch/hydrolysates.

2. Does it work in treating those conditions? Summarize the evidence.

• Improving hyperglycemia and insulin sensitivity (mouse model evidence):

  • In db/db mice, jicama extract given for 6 weeks led to significantly lower blood glucose and glycosylated hemoglobin versus diabetic controls, and improved glucose and insulin tolerance tests (increased insulin sensitivity).

  • Mechanistically, the same study reported increased skeletal muscle signaling/transport markers (e.g., phosphorylated AMPK, AS160, and plasma membrane GLUT4) and decreased hepatic gluconeogenesis enzyme expression (glucose-6-phosphatase, PEPCK), consistent with improved insulin action and reduced glucose production.

  • Limitations: These are animal data; the abstract does not provide dose standardization details here, and results may not translate directly to humans.

• Reducing postprandial glucose via digestive enzyme inhibition (mouse + in vitro enzyme evidence):

  • Jicama extract inhibited α-glucosidase and α-amylase with reported IC50 values of 0.083 ± 0.004 mg/mL and 0.091 ± 0.017 mg/mL, respectively.

  • In STZ-induced diabetic mice (and also normal mice), jicama extract significantly suppressed post-meal blood glucose rises and reduced glucose area-under-the-curve (AUC) (P<0.05 in diabetic mice).

  • Limitations: Enzyme inhibition and acute postprandial effects do not prove long-term diabetes control in humans; STZ models reflect insulin-deficient diabetes physiology more than classic type 2 diabetes.

• Preventing diet-induced dysglycemia and weight gain (mouse dietary fiber evidence):

  • In BALB/c mice fed a high-sucrose diet, adding 25% jicama fiber significantly prevented blood glucose increases, excessive body weight gain, and glucose intolerance over 8 weeks.

  • Both 10% and 25% jicama fiber blunted high-sucrose-diet-induced white adipose tissue mass gain, though it did not prevent depletion of brown adipose tissue mass.

  • Limitations: The fiber percentage is very high relative to typical human diets; applicability to realistic intakes is uncertain.

• Prebiotic/synbiotic effects in a diabetes model (Drosophila evidence):

  • Jicama extract used as a prebiotic inulin source combined with probiotics (Lactiplantibacillus plantarum, Enterococcus faecium) reduced lipid droplet deposition, gut micronuclei, triglycerides, insulin-like gene overexpression (Dilp2, Dilp5), and ROS in a high-fat diet Drosophila model; synbiotic performed better than probiotics alone.

  • Limitations: Drosophila findings are hypothesis-generating and not direct clinical evidence.

• Low glycemic index classification (food property evidence):

  • A maturation-stage study reported jicama as a low glycemic index food (GI < 25), alongside changes in polysaccharides (inulin early, other fructooligosaccharides such as nystose, increasing pectin/galacturonic acid and starch with development).

  • Limitations: The abstract does not describe human GI testing methods; “GI < 25” is supportive but should be interpreted cautiously without full methodology.

3. What health benefits does it have?

• Glycemic benefits (preclinical):

  • Lower fasting/overall glycemia markers (blood glucose, glycosylated hemoglobin) and improved insulin sensitivity in db/db mice given jicama extract.

  • Reduced postprandial glucose excursions in STZ-diabetic and normal mice, consistent with α-glucosidase/α-amylase inhibition.

  • Prevention of high-sucrose-diet-induced glucose intolerance and weight gain with high-dose jicama fiber in mice.

• Prebiotic potential (composition + model evidence):

  • Analytical confirmation of inulin in jicama roots (highest early in development) and presence of other fructooligosaccharides (e.g., nystose), which are commonly considered prebiotic carbohydrates.

  • In a Drosophila high-fat diet model, jicama-derived inulin used in a synbiotic reduced metabolic and oxidative stress-related readouts more than probiotics alone.

  • Formulation studies (synbiotic powders; fermented milk with jicama starch) suggest jicama ingredients can be used as carriers/supports for probiotics, with reported maintenance of probiotic viability in a freeze-dried synbiotic powder context.

• Antioxidant-related properties (food composition evidence):

  • In an Andean foods survey, jícama (Smallanthus sonchifolius) had the highest total phenolics, flavonoids, and total antioxidant capacity among tubers assessed, suggesting potential dietary antioxidant contribution.

  • Limitation: Antioxidant capacity assays in foods do not necessarily translate into clinically meaningful antioxidant effects in humans.

• Low glycemic index as a food characteristic:

  • The maturation study classifying jicama as GI < 25 supports its potential usefulness as a carbohydrate source with relatively low glycemic impact.

4. Does it have any downsides or side effects?

• Human safety/side-effect data are not provided in these abstracts:

  • None of the included abstracts report adverse events, tolerability outcomes, or toxicity assessments in humans.

• Potential GI side effects are plausible but not demonstrated here:

  • Because jicama contains inulin and other fructooligosaccharides, some individuals may experience gas, bloating, or diarrhea at higher intakes (a known issue with many inulin/FOS sources), but these abstracts do not measure such effects.

• High-dose fiber formulations may not be practical:

  • The mouse study used diets containing up to 25% jicama fiber, which is far above typical human dietary patterns; extrapolating benefits (or tolerability) to normal intakes is uncertain.

• Species/plant-identity ambiguity across “jicama” terms:

  • One abstract refers to “jícama” as Smallanthus sonchifolius (commonly known as yacón in many regions), while another discusses Pachyrhizus erosus starch. This matters because composition and safety profiles can differ by species; the abstracts do not reconcile these differences.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

No pharmacogenomic findings are reported in these abstracts.

• No genotype-stratified responses: None of the studies evaluate outcomes by human genetic variants (e.g., variants affecting carbohydrate digestion, insulin signaling, or microbiome interactions).

• Mechanistic signals are not pharmacogenomics: The db/db mouse study reports changes in metabolic signaling proteins (e.g., AMPK phosphorylation, GLUT4 translocation-related markers), but it does not link effects to genetic polymorphisms or predict differential responses by genotype.

• Practical implication: Based on these abstracts alone, there is insufficient evidence to claim jicama is specifically beneficial or harmful for any particular genetic variation.

References

1. Chemical Composition and Antioxidant Activity of the Main Fruits, Tubers and Legumes Traditionally Consumed in the Andean Regions of Ecuador as a Source of Health-Promoting Compounds.
   Doménica Pérez-Balladares, Michael Castañeda-Terán, María G Granda-Albuja, Eduardo Tejera, Gabriel Iturralde, Silvana Granda-Albuja, Tatiana Jaramillo-Vivanco, Francesca Giampieri, Maurizio Battino, José M Alvarez-Suarez (2019) - Plant foods for human nutrition (Dordrecht, Netherlands)
2. Polysaccharides of nutritional interest in jicama (
   Marcela González-Vázquez, Georgina Calderón-Domínguez, Rosalva Mora-Escobedo, Ma Paz Salgado-Cruz, José Honorato Arreguín-Centeno, Ricardo Monterrubio-López (2022) - Food science & nutrition
3. Treating the Onset of Diabetes Using Probiotics Along with Prebiotic from Pachyrhizus erosus in High-Fat Diet Fed Drosophila melanogaster.
   Amrita Bhanja, Nibedita Nayak, Sumit Mukherjee, Parag Prakash Sutar, Monalisa Mishra (2022) - Probiotics and antimicrobial proteins
4. Removal of dye using peroxidase-immobilized Buckypaper/polyvinyl alcohol membrane in a multi-stage filtration column via RSM and ANFIS.
   Yien Jun Lau, Rama Rao Karri, Nabisab Mujawar Mubarak, Sie Yon Lau, Han Bing Chua, Mohammad Khalid, Priyanka Jagadish, Ezzat Chan Abdullah (2020) - Environmental science and pollution research international
5. Effect of nanofibers fraction on properties of the starch based biocomposite prepared in various ultrasonic powers.
   Hairul Abral, Arya Satya Anugrah, Fadli Hafizulhaq, Dian Handayani, Eni Sugiarti, Ahmad Nove Muslimin (2018) - International journal of biological macromolecules
6. The effect of jicama (
   Sri Melia, Indri Juliyarsi, Rizki D Setiawan, Salam N Aritonang, Hurriya Alzahrah, Doni Supandil (2024) - Journal of advanced veterinary and animal research
7. Jicama (Pachyrhizus erosus) extract increases insulin sensitivity and regulates hepatic glucose in C57BL/Ksj-db/db mice.
   Chan Joo Park, Hyun-Ah Lee, Ji-Sook Han (2016) - Journal of clinical biochemistry and nutrition
8. Jicama (
   Putra Santoso, Astri Amelia, Resti Rahayu (2019) - Journal of advanced veterinary and animal research
9. Hypoglycemic Effect of Jicama (Pachyrhizus erosus) Extract on Streptozotocin-Induced Diabetic Mice.
   Chan Joo Park, Ji-Sook Han (2015) - Preventive nutrition and food science
10. Transcriptional analysis of oxidative-tolerant and temperature-sensitive genes of Bifidobacterium animalis BF052 during freeze-drying process and development of its soymilk-synbiotic product containing banana and jicama powders.
    Sirima Suvarnakuta Jantama, Pachamon Pichayajittipong, Ratsadakorn Yimsabai Maneewong, Kuan-Chen Cheng, Kaemwich Jantama (2025) - Food research international (Ottawa, Ont.)
11. Synthesis of Jicama (
    Fatima Sarahi Serrano-Villa, Eduardo Morales-Sánchez, José Alfredo Téllez-Morales, Verónica Cuellar-Sánchez, Reynold R Farrera-Rebollo, Georgina Calderón-Domínguez (2025) - Polymers